| Class 2 Device Recall Xpert Xpress Strep A |  |
Date Initiated by Firm | April 24, 2023 |
Date Posted | November 02, 2023 |
Recall Status1 |
Open3, Classified |
Recall Number | Z-0215-2024 |
Recall Event ID |
93125 |
510(K)Number | K172126 |
Product Classification |
Groups A, C and G beta-hemolytic streptococcus nucleic acid amplification system - Product Code PGX
|
Product | Xpert Xpress Strep A, XPRSTREPA-10, P/N: 302-2294 IVD, Rx Only |
Code Information |
UDI: (01)07332940006372/ Lots: 23718 23719 23720 10309 23201 23305 23308 23312 23314 23315 23401 23402 23403 23404 23405 23406 23407 23501 23504 23505 23506 23408 23410 23510 23411 23604 23605 23607 23608 23609 23610 23611 23612 23701 23702 23703 23705 23706 23707 23708 23709 23710 23711 23712 23714 23716 23717 23113 23316 23912 24112 23820 24704 24302 24307 24507 24508 24511 23822 23823 23824 24512 24513 24514 23825 24313 24515 24516 24517 24805
|
Recalling Firm/ Manufacturer |
Cepheid 904 E Caribbean Dr Sunnyvale CA 94089-1189
|
For Additional Information Contact | Darwa Peterson 408-242-7380 |
Manufacturer Reason for Recall | pipettes packaged in Strep A test may fail to dispense an adequate sample volume which could result in "invalid" results or no result test results. |
FDA Determined Cause 2 | Unknown/Undetermined by firm |
Action | On April 28, 2023, Cepheid issued a Important product recall notification to affected consignees via FedEx. In addition to informing consignees about the recall, Cepheid ask consignees to take the following action:
2. If, upon following this guideline for proper use of the pipette you determine that your pipette fails to aspirate an
adequate volume of liquid, repeat the steps using a new pipette.
3. We ask that you acknowledge receipt of this Important Product Notice by responding via a web request from https://www.cepheid.com/streppipette (for US customer only) or by completing the enclosed Customer Response Form (email or Fax). In addition, replacement pipettes, if needed, can be requested via the above mentioned process.
Please complete this activity within 10 days, so we are assured you have received this important communication. The Customer Response Form can be emailed to CFQ@cepheid.com or faxed to +1 (408) 716-3143.
4. Please share this information with your laboratory staff and retain this notification as part of your laboratory Quality System documentation. If you have forwarded any of the affected product(s) listed above to another laboratory, please provide them a copy of this letter.
|
Quantity in Commerce | 89,958 kits ( 10 test per kit) |
Distribution | Worldwide distribution - US Nationwide and the countries of Costa Rica, Ireland, Estonia, United Kingdom, Germany, Italy, Greece, Poland, Switzerland, Hong Kong, United Arab Emirates. |
Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 The manufacturer has initiated the recall and not all products have been corrected or removed. This record will be updated as the status changes.
|
510(K) Database | 510(K)s with Product Code = PGX
|
|
|
|